(19)
(11) EP 4 149 552 A1

(12)

(43) Date of publication:
22.03.2023 Bulletin 2023/12

(21) Application number: 21803283.7

(22) Date of filing: 14.05.2021
(51) International Patent Classification (IPC): 
A61K 41/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 45/06; A61K 31/495; A61K 31/4965
 
C-Sets:
  1. A61K 31/495, A61K 2300/00;
  2. A61K 31/4965, A61K 2300/00;
(86) International application number:
PCT/US2021/032461
(87) International publication number:
WO 2021/231872 (18.11.2021 Gazette 2021/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.05.2020 US 202063025770 P

(71) Applicant: Healion Bio, Inc.
Frederick, MD 21704 (US)

(72) Inventors:
  • BAVARI, Sina
    Frederick, Maryland 21702 (US)
  • NEWMAN, Simon
    Ijamsville, Maryland 21754 (US)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham, West Midlands B16 8QQ
Birmingham, West Midlands B16 8QQ (GB)

   


(54) COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUG